DK142513B - Reagens, især et flydende reagens, som agglutinerer, når det bringes i kontakt med væsker indeholdende human-choriongonadotropin, og fremgangsmåde til fremstilling af reagenset. - Google Patents
Reagens, især et flydende reagens, som agglutinerer, når det bringes i kontakt med væsker indeholdende human-choriongonadotropin, og fremgangsmåde til fremstilling af reagenset. Download PDFInfo
- Publication number
- DK142513B DK142513B DK574776AA DK574776A DK142513B DK 142513 B DK142513 B DK 142513B DK 574776A A DK574776A A DK 574776AA DK 574776 A DK574776 A DK 574776A DK 142513 B DK142513 B DK 142513B
- Authority
- DK
- Denmark
- Prior art keywords
- approx
- reagent
- chorionic gonadotropin
- human chorionic
- buffered
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 61
- 229940084986 human chorionic gonadotropin Drugs 0.000 title claims description 26
- 102000011022 Chorionic Gonadotropin Human genes 0.000 title claims description 24
- 108010062540 Chorionic Gonadotropin Proteins 0.000 title claims description 24
- 239000007788 liquid Substances 0.000 title claims description 11
- 238000000034 method Methods 0.000 title claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 239000004816 latex Substances 0.000 claims description 22
- 229920000126 latex Polymers 0.000 claims description 22
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 18
- 210000002966 serum Anatomy 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 229960002449 glycine Drugs 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 8
- 229940098773 bovine serum albumin Drugs 0.000 claims description 8
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 8
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 8
- 239000004793 Polystyrene Substances 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 229920002223 polystyrene Polymers 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 3
- CVVIJWRCGSYCMB-UHFFFAOYSA-N hydron;piperazine;dichloride Chemical compound Cl.Cl.C1CNCCN1 CVVIJWRCGSYCMB-UHFFFAOYSA-N 0.000 claims description 3
- 102000005686 Serum Globulins Human genes 0.000 claims description 2
- 108010045362 Serum Globulins Proteins 0.000 claims description 2
- 229940015047 chorionic gonadotropin Drugs 0.000 claims description 2
- XVDIJUOSZVRXCQ-UHFFFAOYSA-M sodium;piperazine;hydroxide;dihydrochloride Chemical compound [OH-].[Na+].Cl.Cl.C1CNCCN1 XVDIJUOSZVRXCQ-UHFFFAOYSA-M 0.000 claims description 2
- 210000002700 urine Anatomy 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000035935 pregnancy Effects 0.000 description 7
- 230000004520 agglutination Effects 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000009597 pregnancy test Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 102000006395 Globulins Human genes 0.000 description 4
- 108010044091 Globulins Proteins 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69191576 | 1976-06-01 | ||
| US05/691,915 US4003988A (en) | 1976-06-01 | 1976-06-01 | Direct agglutination test for pregnancy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK574776A DK574776A (zh) | 1977-12-02 |
| DK142513B true DK142513B (da) | 1980-11-10 |
| DK142513C DK142513C (zh) | 1981-07-13 |
Family
ID=24778485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK574776AA DK142513B (da) | 1976-06-01 | 1976-12-21 | Reagens, især et flydende reagens, som agglutinerer, når det bringes i kontakt med væsker indeholdende human-choriongonadotropin, og fremgangsmåde til fremstilling af reagenset. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4003988A (zh) |
| JP (1) | JPS52148618A (zh) |
| AR (1) | AR210183A1 (zh) |
| AT (1) | AT349650B (zh) |
| AU (1) | AU505765B2 (zh) |
| BE (1) | BE849085A (zh) |
| CA (1) | CA1083957A (zh) |
| CH (1) | CH631266A5 (zh) |
| DE (1) | DE2651139C3 (zh) |
| DK (1) | DK142513B (zh) |
| ES (1) | ES453609A1 (zh) |
| FR (1) | FR2353858A1 (zh) |
| GB (1) | GB1561920A (zh) |
| IE (1) | IE44204B1 (zh) |
| IT (1) | IT1066737B (zh) |
| LU (1) | LU76374A1 (zh) |
| NL (1) | NL7613350A (zh) |
| NO (1) | NO148200C (zh) |
| SE (1) | SE422501B (zh) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4092114A (en) * | 1976-10-20 | 1978-05-30 | Fisher Scientific Company | Indirect latex test for determination of immunoglobulins |
| US4411518A (en) * | 1977-09-23 | 1983-10-25 | Gamma Biologicals, Inc. | Apparatus for use in qualitative determination of immunological reactions |
| US4197088A (en) * | 1977-09-23 | 1980-04-08 | Akro-Medic Engineering, Inc. | Method for qualitative and quantitative determination of immunological reactions |
| JPS5816471B2 (ja) * | 1977-11-29 | 1983-03-31 | 持田製薬株式会社 | 免疫化学的測定試薬の安定化剤 |
| US4138214A (en) * | 1977-12-19 | 1979-02-06 | American Home Products Corporation | Diagnostic test utilizing human chorionic gonadotropin |
| JPS55166028A (en) * | 1979-06-13 | 1980-12-24 | Mitsubishi Chem Ind Ltd | Optical measurement of liquid sample |
| US4259207A (en) * | 1979-09-19 | 1981-03-31 | American Hospital Supply Corporation | Suspending medium for immunologic reactions |
| US4340564A (en) * | 1980-07-21 | 1982-07-20 | Daryl Laboratories, Inc. | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate |
| US4348207A (en) * | 1981-01-29 | 1982-09-07 | Cooper Laboratories, Inc. | Method and means for determination of pregnancy |
| IL63855A (en) * | 1981-09-16 | 1984-10-31 | Teva Pharma | Method and kit for detecting pregnancy |
| US4543339A (en) * | 1982-03-16 | 1985-09-24 | Oneill Christopher | Early pregnancy detection by detecting enhanced blood platelet activation |
| US4542103A (en) * | 1982-09-13 | 1985-09-17 | Miles Laboratories Inc. | Latex agglutination determination of IgG in neonatals and in colostrum |
| DE3303083A1 (de) * | 1983-01-31 | 1984-08-02 | Behringwerke Ag, 3550 Marburg | Immunologisches latex-agglutinationsverfahren und mittel |
| US4720465A (en) * | 1985-05-14 | 1988-01-19 | Fisher Scientific Company | Centrifugal kinetic agglutination assay |
| JPH0827283B2 (ja) * | 1986-03-10 | 1996-03-21 | 財団法人化学及血清療法研究所 | 免疫凝集反応用組成物 |
| IT1223295B (it) | 1987-08-14 | 1990-09-19 | Boehringer Biochemia Srl | Dispositivo e metodo immunodiagnostico |
| US5900379A (en) * | 1996-04-11 | 1999-05-04 | Mizuho Usa, Inc. | Analytical device |
| US7410807B2 (en) * | 2000-07-24 | 2008-08-12 | D Aurora Vito J | Pregnancy and sex identification test based on saliva or other bodily fluids |
| US7705335B2 (en) * | 2007-03-16 | 2010-04-27 | Parttec, Ltd. | Security protection device and method |
| CN104155458A (zh) * | 2013-11-27 | 2014-11-19 | 新昌县美迪生物科技有限公司 | 人绒毛膜促性腺激素定量检测试剂盒及其用途 |
| US20150044707A1 (en) | 2014-02-18 | 2015-02-12 | Melinda Sanders | At-Home Blood Pregnancy Test Kit |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3088875A (en) * | 1959-10-27 | 1963-05-07 | Hyland Lab | Immunological diagnostics utilizing polystyrene latex particles of 0.15 to 0.25 micron |
| NL266403A (zh) * | 1960-06-28 | |||
| US3236732A (en) * | 1962-01-22 | 1966-02-22 | Edward R Arquilla | Pregnancy test method and immunological indicator therefor |
| BE613680A (zh) * | 1961-03-07 | |||
| US3171783A (en) * | 1962-08-15 | 1965-03-02 | Hyland Lab | Diagnostic procedure |
| BE641877A (zh) * | 1962-12-28 | |||
| FR1411279A (fr) * | 1963-08-23 | 1965-09-17 | Ortho Pharma Corp | Procédé de fabrication d'un réactif pour la détection de la gonadotrophine chorionique humaine dans l'urine dans le test d'inhibition sérologique et procédé de détection de la gch dans l'urine par utilisation de ce réactif |
| NL132816C (zh) * | 1963-08-23 | |||
| GB1078939A (en) * | 1964-08-12 | 1967-08-09 | Pfizer & Co C | Diagnostic reagent |
| NL125235C (zh) * | 1965-04-15 | |||
| NL130516C (zh) * | 1966-11-08 | |||
| US3873683A (en) * | 1968-12-10 | 1975-03-25 | Princeton Lab Inc | Pregnancy test composition and method |
| US3655838A (en) * | 1969-03-20 | 1972-04-11 | Organon | Method of pelletizing analytical or immunological reagents |
-
1976
- 1976-06-01 US US05/691,915 patent/US4003988A/en not_active Expired - Lifetime
- 1976-11-02 IE IE2437/76A patent/IE44204B1/en unknown
- 1976-11-09 DE DE2651139A patent/DE2651139C3/de not_active Expired
- 1976-11-11 AU AU19546/76A patent/AU505765B2/en not_active Expired
- 1976-11-11 IT IT52135/76A patent/IT1066737B/it active
- 1976-11-19 NO NO763966A patent/NO148200C/no unknown
- 1976-11-23 AR AR265572A patent/AR210183A1/es active
- 1976-11-23 GB GB48765/76A patent/GB1561920A/en not_active Expired
- 1976-11-24 ES ES453609A patent/ES453609A1/es not_active Expired
- 1976-11-26 CH CH1494076A patent/CH631266A5/de not_active IP Right Cessation
- 1976-11-30 NL NL7613350A patent/NL7613350A/xx not_active Application Discontinuation
- 1976-11-30 FR FR7636035A patent/FR2353858A1/fr active Granted
- 1976-12-03 BE BE6045785A patent/BE849085A/xx not_active IP Right Cessation
- 1976-12-07 CA CA267,319A patent/CA1083957A/en not_active Expired
- 1976-12-13 LU LU76374A patent/LU76374A1/xx unknown
- 1976-12-16 JP JP15144576A patent/JPS52148618A/ja active Pending
- 1976-12-21 DK DK574776AA patent/DK142513B/da not_active IP Right Cessation
- 1976-12-22 AT AT955076A patent/AT349650B/de not_active IP Right Cessation
- 1976-12-30 SE SE7614724A patent/SE422501B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT349650B (de) | 1979-04-10 |
| SE422501B (sv) | 1982-03-08 |
| AU505765B2 (en) | 1979-11-29 |
| US4003988A (en) | 1977-01-18 |
| LU76374A1 (zh) | 1977-06-10 |
| FR2353858A1 (fr) | 1977-12-30 |
| ATA955076A (de) | 1978-09-15 |
| AR210183A1 (es) | 1977-06-30 |
| IT1066737B (it) | 1985-03-12 |
| NO148200B (no) | 1983-05-16 |
| DE2651139C3 (de) | 1979-07-26 |
| DK574776A (zh) | 1977-12-02 |
| BE849085A (fr) | 1977-06-03 |
| DE2651139B2 (de) | 1978-11-23 |
| NO148200C (no) | 1983-08-24 |
| JPS52148618A (en) | 1977-12-10 |
| CH631266A5 (de) | 1982-07-30 |
| ES453609A1 (es) | 1978-03-16 |
| IE44204L (en) | 1977-12-01 |
| AU1954676A (en) | 1978-05-18 |
| IE44204B1 (en) | 1981-09-09 |
| NO763966L (no) | 1977-12-02 |
| GB1561920A (en) | 1980-03-05 |
| DK142513C (zh) | 1981-07-13 |
| FR2353858B1 (zh) | 1980-08-29 |
| NL7613350A (nl) | 1977-12-05 |
| SE7614724L (sv) | 1977-07-07 |
| DE2651139A1 (de) | 1977-12-15 |
| CA1083957A (en) | 1980-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK142513B (da) | Reagens, især et flydende reagens, som agglutinerer, når det bringes i kontakt med væsker indeholdende human-choriongonadotropin, og fremgangsmåde til fremstilling af reagenset. | |
| Cannon et al. | An improved serologic method for the determination of the precipitative titers of antisera | |
| US4248965A (en) | Immunochemical process of measuring physiologically active substances | |
| Fagraeus et al. | Mixed haemadsorption: A mixed antiglobulin reaction applied to antigens on a glass surface: Preparation and evaluation of indicator red cells; survey of present applications | |
| US4259207A (en) | Suspending medium for immunologic reactions | |
| US5514557A (en) | Method and kit for detecting antibodies specific for HLA and/or platelet glycoproteins | |
| IE44471B1 (en) | Stable preparation of erythrocytes process for preparing it and its use | |
| Kaplan | Cryoglobulinemia in infectious mononucleosis: quantitation and characterization of the cryoproteins | |
| Ingraham | The preparation and use of formalinized erythrocytes with attached antigens or haptens to titrate antibodies | |
| Brinkman et al. | Alkaline resistance and spreading velocity of foetal and adult types of mammalian haemoglobin | |
| Vaughan et al. | Quantitative considerations of the rheumatoid factor | |
| CA1168580A (en) | Immunological reagent for the detection of tubes of the rheumatoid factor in a biological specimen and process for preparing this novel reagent | |
| Pondman et al. | The specificity of the complement antiglobulin test | |
| DK171813B1 (da) | Fremgangsmåde til fremstilling af partikelstabiliserede epitoper til standardisering og kontrol af immunbestemmelser, sammensætninger, der omfatter sådanne epitoper, samt immunbestemmelsessæt til måling af lipoprotein | |
| CA1114743A (en) | Erythrocytes selectively sensitized with c3 complement component | |
| Peterson et al. | Sudden infant death syndrome and hypertriiodothyroninemia: Comparison of neonatal and postmortem measurements | |
| US4331649A (en) | Immune complex assay | |
| CA1149737A (en) | S-alkylated igg antibody for immunoassay | |
| Mygind et al. | IgG cold agglutinins and first trimester abortion | |
| CN113219183B (zh) | 一种液态胶血型检测卡、制备方法及血型检测系统 | |
| Poschmann et al. | Persistent Mixed Field Polyagglutinability: An Immunofluorescence Study in Genetically Abnormal Red Cells 1 | |
| US3697639A (en) | Serological test for the detection of hepatitis | |
| US4282002A (en) | Sensitized sheep stroma immunoassay for rheumatoid factor | |
| US4540565A (en) | Reduced IgG in low ionic strength medium for immunohematologic agglutination | |
| RU2021815C1 (ru) | Способ диагностики алеутской болезни норок |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |